WATSON 425
Pill imprint WATSON 425 has been identified as Aspirin, butalbital, caffeine and codeine phosphate 325 mg / 50 mg / 40 mg / 30 mg.
Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy.
Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg has a moderate potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
See also related documents.
Aspirin, butalbital, caffeine and codeine phosphate Images
- Imprint:
-
WATSON 425
- Strength:
- 325 mg / 50 mg / 40 mg / 30 mg
- Color:
- Blue & Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 3 - Moderate abuse potential
- Manufacturer:
- Watson Pharmaceuticals
Advertisement
More Aspirin, Butalbital, Caffeine and Codeine Phosphate resources
- Aspirin, Butalbital, Caffeine and Codeine Phosphate Side Effects
- Aspirin, Butalbital, Caffeine and Codeine Phosphate Use in Pregnancy & Breastfeeding
- Aspirin, Butalbital, Caffeine and Codeine Phosphate Drug Interactions
- Support Group Q & A
- 14 Reviews for Aspirin, Butalbital, Caffeine and Codeine Phosphate - Add your own review/rating
- Aspirin/Butalbital/Caffeine/Codeine (Wolters Kluwer)
- aspirin, butalbital, caffeine, and codeine (Cerner Multum)
- Butalbital,Aspirin,Caffeine,Codeine (FDA)
- Butalbital/Aspirin/Caffeine/Codeine Phosphate (Wolters Kluwer)
Search Again
